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Identification of loci 
associated with susceptibility 
to bovine paratuberculosis 
and with the dysregulation 
of the MECOM, eEF1A2, and U1 
spliceosomal RNA expression
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Marta Alonso‑Hearn1*
Although genome‑wide association studies have identified single nucleotide polymorphisms 
(SNPs) associated with the susceptibility to Mycobacterium avium subsp. paratuberculosis (MAP) 
infection, only a few functional mutations for bovine paratuberculosis (PTB) have been characterized. 
Expression quantitative trait loci (eQTLs) are genetic variants typically located in gene regulatory 
regions that alter gene expression in an allele‑specific manner. eQTLs can be considered as functional 
links between genomic variants, gene expression, and ultimately phenotype. In the current study, 
peripheral blood (PB) and ileocecal valve (ICV) gene expression was quantified by RNA‑Seq from 
fourteen Holstein cattle with no lesions and with PTB‑associated histopathological lesions in gut 
tissues. Genotypes were generated from the Illumina LD EuroG10K BeadChip. The associations 
between gene expression levels (normalized read counts) and genetic variants were analyzed 
by a linear regression analysis using R Matrix eQTL 2.2. This approach allowed the identification 
of 192 and 48 cis‑eQTLs associated with the expression of 145 and 43 genes in the PB and ICV 
samples, respectively. To investigate potential relationships between these cis‑eQTLs and MAP 
infection, a case–control study was performed using the genotypes for all the identified cis‑eQTLs 
and phenotypical data (histopathology, ELISA for MAP‑antibodies detection, tissue PCR, and 
bacteriological culture) of 986 culled cows. Our results suggested that the heterozygous genotype in 
the cis‑eQTL‑rs43744169 (T/C) was associated with the up‑regulation of the MDS1 and EVI1 complex 
(MECOM) expression, with positive ELISA, PCR, and bacteriological culture results, and with increased 
risk of progression to clinical PTB. As supporting evidence, the presence of the minor allele was 
associated with higher MECOM levels in plasma samples from infected cows and with increased MAP 
survival in an ex‑vivo macrophage killing assay. Moreover, the presence of the two minor alleles in the 
cis‑eQTL‑rs110345285 (C/C) was associated with the dysregulation of the eukaryotic elongation factor 
1‑α2 (eEF1A2) expression and with increased ELISA (OD) values. Finally, the presence of the minor 
allele in the cis‑eQTL rs109859270 (C/T) was associated with the up‑regulation of the U1 spliceosomal 
RNA expression and with an increased risk of progression to clinical PTB. The introduction of these 
novel functional variants into marker‑assisted breeding programs is expected to have a relevant effect 
on PTB control.
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Paratuberculosis (PTB) is a gastrointestinal disease of domestic and wild ruminants caused by Mycobacterium 
avium susbp. paratuberculosis (MAP). PTB causes direct economic losses to the dairy farms due to decreased 
milk production, replacement cost, and premature culling or death from the clinical  disease1,2. The most common 
clinical signs are progressive weight loss, diarrhea, and decreased milk  yield3. PTB is a major problem for animal 
health and must be notified to the World Organization for Animal Health. In addition, MAP is a suspected cause 
of Crohn’s disease (CD) in  humans4. Colorectal cancer is a complication of the two forms of idiopathic inflam-
matory bowel disease (IBD); colonic CD and ulcerative colitis. Interestingly, MAP bacilli have been detected in 
the intestines of patients with CD, ulcerative colitis, and IBD-associated colorectal  cancer5,6.
Improving host genetics through selective breeding could enhance natural resistance to MAP infection and 
complement existing control  strategies7–9. Over the last decade, different strategies including case–control studies 
in candidate genes and genome-wide association studies (GWAS) identified single nucleotide polymorphisms 
(SNPs) significantly associated with susceptibility to bovine  PTB10–16. However, few SNPs were identified with 
consistent association across studies and the molecular mechanisms by which they contribute to disease remain 
largely unknown. Recent studies using RNA next-generation sequence technology (RNA-Seq) have been con-
ducted to gain a better understanding of the molecular mechanisms involved in the circulating and local response 
against a natural MAP  infection17–19. While transcriptomic studies provide insight into the genes and mechanisms 
involved in the response to MAP infection, they do not reveal whether there is variation in the transcriptional 
response among individuals and how this might influence PTB outcome.
Jansen and  Nap20 introduced the concept of “genetical genomics” where genomic variants were associated with 
transcript abundance which acts as a heritable endophenotype. This concept supported the idea that integrating 
genomic variants and gene expression data could contribute to a better understanding of the genetic architecture 
underlying disease outcome (an endpoint phenotype)21,22. Polymorphisms associated with gene expression are 
known as expression quantitative trait loci (eQTLs). In a cis position (within 1 Mb upstream of the transcription 
start site of a gene locus), cis-eQTLs might alter transcription regulation, mRNA stability, or mRNA  splicing23,24. 
This leads to changes in the level, timing, and/or localization of gene expression which can significantly influence 
variations in individual phenotype. In the current study, we hypothesized that individual genetic variation in the 
transcriptional response to PTB infection might have implications in disease outcome. The main objective was to 
identify cis-eQTLs significantly associated with changes in gene expression levels in peripheral blood (PB) and 
ileocecal valve (ICV) samples collected from Holstein cattle with no lesions and with PTB-associated lesions in 
gut tissues. Next, we assessed whether the genes with cis-eQTLs were DE in PTB-infected cows versus control 
cows. Finally, to test whether the identified cis-eQTLs affected not just gene expression but also the PTB risk, a 
case–control study using the genotypes of all the identified cis-eQTLs and the phenotypical data of a cohort of 
986 culled cattle was performed. The workflow of the study is presented in Fig. 1.
Results
RNA‑Seq data and genotypes. Samples from the animals included in this study were tested by ELISA 
for the detection of MAP-specific antibodies, qPCR for MAP DNA detection, bacteriological culture, and his-
topathological analysis, as previously described (Table 1)18. All control animals (N = 4) were negative for all the 
diagnostic tests. In contrast, the infected cows had detectable lesions in gut tissues with distinct severity; focal/
multifocal (N = 6) or diffuse (N = 4). RNA-extraction from PB and ICV samples of the fourteen cows, RNA-Seq 
libraries preparation, and sequencing using an Illumina NextSeq500 sequencer were performed as previously 
 described18. The raw reads were filtered by their length (minimum size 75 bp long) and percentage of ambiguous 
base N less than 10% using Prinseq-lite 0.20.425. Then, the trimmed sequences were mapped to the Bos Taurus 
reference genome (Bos_taurus.UMD3.1. version 87) with TopHat 2.1.1.26. In the current study, the mapped 
reads were quantified with RSubread to calculate gene expression levels (read counts)27. In addition, genomic 
DNA was extracted from PB samples of the fourteen animals and subsequently genotyped using the Illumina 
MD EuroG10K BeadChip (54,609 SNPs) as previously  described28. Altogether the study is comprised of 54,609 
genetic variants and expression values of 24,616 genes in 28 samples.
cis‑eQTL analysis. Gene expression data (read counts) were normalized with the mean-of-ratios method 
included in the DESeq 2  package29. Our integrated genomic-transcriptomic dataset was analyzed for associations 
between SNPs-normalized read counts using R Matrix eQTL 2.230 including the age of slaughter as a covariate. 
Matrix eQTL tests for associations between SNPs-normalized read counts by modeling the effect of genotype as 
additive linear (least square model). cis-eQTLs were identified by including all the variants on the same chromo-
some that are located 1 Mb upstream of the transcription start site (TSS) of a gene locus. A genetic variant was 
regarded as a significant cis-eQTL for a given gene if  PFDR ≤ 0.05. For the PB samples, two analyses were per-
formed including all the tested genetic variants located within 0.5 and 1 Mb upstream of the TSS of a gene locus; 
Fig. 2a,b respectively. Using the 24,616 mapped genes, we identified 96 and 192 cis-eQTLs which were associated 
with 76 and 145 genes, respectively. As expected, all the cis-eQTLs identified in the first analysis were validated 
when the analysis was extended 1 Mb upstream of the TSS of a gene locus. Using the ICV datasets, the SNPs-
reads association analysis allowed the identification of 48 cis-eQTLs located within 0.5 Mb upstream of a TSS 
and associated with the expression of 43 genes (Fig. 2c). As expected, all the identified cis-eQTLs were located 
on the same chromosome as the associated gene. Most of the identified cis-eQTLs were located in intronic or 
intergenic regions (Fig.  2d–f). The complete cis-eQTL discovery in the PB and ICV samples is presented in 
Tables S1–S3.
The cis-eQTL (rs109475758) with the lowest  PFDR  (PFDR = 4593E−14) in the PB dataset was associated with 
the obscurin (OBSC) gene (Table S1), a highly mutated gene in different types of cancer. The rs109475758 het-
erozygous genotype (T/G) resulted in increased counts of the OBSC gene while the most frequent homozygous 
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Figure 1.  Study design. The approach starts from the individual expression levels, then identifies genetic 
variants controlling differences in gene expression, and finally checks that the identified cis-eQTLs are indeed 
associated with disease outcome.
Table 1.  Histopathological analysis, ELISA, PCR, and bacteriological culture results from all the animals 
included in the current study. DNA samples with a PCR-positive result using the LSI VetMax Triplex real-time 
PCR were quantified using the ParaTB Kuanti-VK kit. qPCR results are expressed as MAP DNA copies per 
gram of feces or tissues × 102. Bacterial load was classified as low (< 10 CFU), medium (between 10 to 50 CFU) 
or heavy (> 50 CFU). ZN Ziehl–Neelsen, OD optical density, CFU colony forming units.
Animal ID
Histopathological analysis
ELISA (OD) Fecal PCR (DNA copies/g  102) Fecal culture
Tissue PCR (DNA copies/g 
 102) Tissue cultureMacroscopic Microscopic ZN
1 No Negative Negative Negative (1.93) Negative Negative Negative Negative
2 No Negative Negative Negative (8.54) Negative Negative Negative Negative
3 No Negative Negative Negative (2.45) Negative Negative Negative Negative
15 No Negative Negative Negative (1.72) Negative Negative Negative Negative
4 No Focal Negative Negative (2.71) Negative Negative Positive (0.38) Negative
5 No Focal Negative Negative (1.03) Negative Negative Positive (7.50) Low
6 No Focal Negative Negative (5.51) Negative Negative Positive (305.28) Negative
7 No Focal Negative Negative (0.74) Negative Negative Positive (12.26) Negative
8 No Focal Negative Positive (133.17) Positive Negative Positive (70.54) Medium
9 No Multifocal Positive Negative (2.97) Negative Negative Negative Negative
10 Yes Diffuse Positive Positive (283.13) Positive Negative Positive (667.65) Heavy
11 Yes Diffuse Positive Positive (187.69) Positive (0.14) Negative Positive (3896.19) Heavy
12 Yes Diffuse Positive Positive (241.18) Positive (114.00) Heavy Positive (104,032) Heavy
14 Yes Diffuse Positive Positive (255.55) Positive (2832.00) Negative Positive (173,316.00) Heavy
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genotype (T/T) correlated with low levels of OBSC gene expression (Fig. 3a). In the ICV samples, the gene with 
the strongest cis-eQTL (rs41753850) association was the apolipoprotein A4 gene (APOA4 ;  PFDR = 8413E−11) 
(Table S3). APOA4 is associated with circulating high-density lipoproteins (HDL) and plays an important role in 
cholesterol transport and lipid metabolism. Interestingly, the rs41753850 was also associated with the apolipopro-
tein C3 (APOC3) gene expression  (PFDR = 0.0031). APOC3 plays an important role in regulating the metabolism 
of triglyceride-rich lipoproteins and has been regarded as a main component of chylomicrons and very-low-
density lipoproteins (VLDL). The heterozygous genotype in the rs41753850 (C/A) resulted in increased levels 
of APOA4 and APOC3 expression, while the most frequent homozygous (C/C) correlated with lower levels of 
APOA4 and APOC3 gene expression (Fig. 3b,c). 
Association between the genes with cis‑eQTLs and MAP infection. We assessed whether the 
genes with cis- eQTLs were DE in PTB-infected cows versus controls (Table 2) using the differential expression 
information generated with the Cufflinks package 2.2.1. in our previous  study18 and with DESeq2 in the current 
study. Despite the small number of control cows, we found that 24 of the genes with cis-eQTLs were DE in the 
PB samples from MAP-infected cows with focal/multifocal (N = 6) or diffuse lesions (N = 4) versus control cows 
(N = 4) (Table 2). Some of these cis-eQTLs-associated genes play key roles in tumorigenicity (OBSC, GSTO1), the 
apoptotic process (CD5L, BNIP3), transcription regulation (PERM1), cell adhesion (NRCAM), platelet aggrega-
tion (GP1Bβ, MRVI1), G-protein coupled receptor signaling pathway (ADCY8, ACKR1), lymphocyte activation 
(HS1BP3), adhesion of blood neutrophils in cytokine-activated endothelium (Selectin E) and in the regulation of 
hypoxia-induced autophagy (ANKRD37) in MAP-infected cattle. In addition, we found that fourteen genes with 
cis-eQTLs were DE in the ICV samples from MAP-infected cows with focal/multifocal or diffuse lesions versus 
control cows (Table 2). Some of these cis-eQTLs-associated genes play key roles in the extracellular matrix struc-
ture (ACAN), negative regulation of NF-kβ (TRIM40), innate immune response (NEURL3, ARSB, Duosenase-1 
like), tumorigenicity (PROM2), G-protein coupled receptor signaling pathway (ACKR1), and oxidative stress 
(PRDX1) in MAP-infected cattle.
To identify common biological functions, enrichment analysis of biological processes was performed with 
the cluster Profiler Bioconductor package 3.10.1.31 using all genes with cis-eQTLs. The rationale is that any change 
to a single gene involved in a process could alter many genes in a biological process and thus the phenotype 
of the animal. Gene ontology enrichment analysis indicated that three genes (C3, S100B, SELENOS) with cis- 
eQTLs were associated with the regulation of acute inflammatory response (GO:0002673) which was significantly 
enriched  (PFDR ≤ 0.05). The heterozygous genotype in the cis-eQTLs of the C3 (Fig. 3d), S100B (Fig. 3e), and 
SELENOS (Fig. 3f) genes resulted in higher gene expression levels;  PFDR = 0.0254,  PFDR = 0.0315 and  PFDR = 0.0320, 
Figure 2.  cis-eQTL analysis. (a,b) PB cis-eQTLs identified within 0.5 (a) and 1 Mb (b) upstream of a TSS. (c) 
ICV cis-eQTLs identified within 0.5 Mb upstream of a TSS. The plots show the − log10 (P-values) of the most 
significant variants for each of the 24,616 analyzed genes. The red line represents the threshold of P = 2.03E−05 
(a), P = 2.14E-05 (b) and P = 1.02E−05 (c). (d,e) The chart depicts the genomic distribution of the PB-cis-eQTLs 
identified within 0.5 (d) and 1 Mb (e) upstream a TSS according to the Ensembl Variant Effect Predictor (VEP). 
(f) Genomic distribution of the ICV cis-eQTLs according to the VEP.
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respectively. In addition, the functional analysis revealed that the cholesterol metabolic route (bta04979) was 
significantly enriched, with the APOA4 and APOC3 genes involved in this route  (PFDR = 0.009, Gene ratio: 2/46). 
This finding reinforced the idea that the APOA4-APOC3 gene cluster may be associated with the PTB risk.
Case–control association study. If the expression levels of a cis-eQTL have any effect on the PTB risk, 
we should observe differences in disease phenotypes among the different genotypes. To address this hypothesis, 
a case–control association study using the genotypes for the 235 identified cis-eQTLs and phenotypical data of 
986 cull Holstein Friesian cows was performed. The infection status of these cows was previously determined by 
histopathological analysis, ELISA, PCR, and bacteriological  culture32. Cattle were classified as cases if they were 
positive for ELISA, PCR culture, and/or if they had PTB-associated lesions in gut tissues. The 986 cows were gen-
otyped for the identified cis-eQTLs and cows with a genotyping rate < 80% were excluded. SNPs deviated signifi-
cantly from the Hardy–Weinberg equilibrium were  removed33. Case–control associations were analyzed with the 
WGassociation function of SNPassoc 1.9.2 under five different genetic models (co-dominant, dominant, reces-
sive, over-dominant, and log-additive)34. P-values were adjusted for multiple comparisons using the Bonferroni 
correction. As seen in Table 3, the rs43744169, rs110345285, and rs109859270 showed significant associations 
with PTB phenotypes. The association analysis using the cis-eQTLs identified with the PB dataset and a minor 
allele frequency (MAF) > 20% revealed significant associations between the cis-eQTL-rs43744169 (T/C) located 
on chromosome 1 and several disease phenotypes including histopathology, ELISA (OD), and ELISA, PCR, and 
bacteriological culture results. The heterozygous genotype (T/C) in the cis-eQTL-rs43744169 was associated 
with the up-regulation of the MDS1 and EVII complex (MECOM) expression (Fig. 3g;  PFDR = 0.00003).
Using a MAF > 10%, an association between the cis-eQTL-rs110345285 (T/C) and mean ELISA (OD) values 
was observed under the codominant and recessive genetic models. The presence of the two minor alleles in the 
cis-eQTL-rs110345285 (C/C) regulating the eukaryotic elongation factor 1-α2 (eEF1A2) expression was associ-
ated with a significant increase in mean OD values (OD = 0.80) when compared with cows with the most frequent 
homozygous genotype (T/T) (OD = 0.29) or with the heterozygous genotype (T/C) (OD = 0.26). The heterozygous 
genotype in the cis-eQTL-rs110345285 (T/C) was associated with the up-regulation of the eEF1A2 expression 
when compared with cows with the most frequent homozygous genotype (T/T) (Fig. 3h;  PFDR = 1.23E−10). Using 
the ICV-identified cis-eQTLs and a MAF > 10%, a significant association between the cis-eQTL-rs109859270 
(C/T) and the absence or presence of PTB-associated lesions was observed. The heterozygous genotype in the 
cis-eQTL-rs109859270 (C/T) located in the bovine chromosome 8 was associated with higher expression levels 
of the U1 spliceosomal RNA (Fig. 3i;  PFDR = 0.0068).
Figure 3.  Boxplots for nine significant cis-eQTLs associations with gene expression. The rs109475758 (a), 
rs41753850 (b,c), rs41591969 (d), rs108986746 (e), rs110435196 (f), rs43744169 (g), rs110345285 (h) and 
rs109859270 (i) were associated with the OBSC, APOA4, APOC3, C3, S100B, SELENOS, MECOM, eEF1A2 and 
U1 spliceosomal RNA expression, respectively. Gene variants are presented on the horizontal axis and gene 
expression levels, normalized gene counts, on the vertical axes. Samples were grouped according to the absence 
of lesions (negative) or the presence of focal/multifocal and diffuse lesions in gut tissues. The median and the 
upper and lower quartiles of each group are represented by horizontal and vertical lines, respectively. The lowest 
point is the minimum of the data set and the highest point is the maximum of the data set.
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The distribution of the rs43744169 and rs109859270 genotypes and odds ratio (OR) for each statistically 
significant genetic model and binary phenotype are presented in Table 4. For the rs43744169, the OR with 
95% confidence interval (CI) under the codominant genetic model for the T/C and C/C genotypes versus the 
T/T genotype were 2.71 (95% CI 1.50–4.88) and 5.36 (95% CI 1.99–14.41) respectively. These results indicated 
Table 2.  Genes with cis-eQTLs that are differentially expressed in response to MAP infection.
Dataset eQTL Gene
Cufflinks 2.2.1-fold change  (log2) DESeq2-fold change  (log2)
Focal vs control Diffuse vs control Focal vs control Diffuse vs control
PB
rs109475758 Obscurin (OBSC) 5.6
rs29014816 CD5 molecule like (CD5L)  − 3.6  − 4.2
rs109079658 PPARGC1 and ESRR induced regulator (PERM1) 4.7
rs109744678 BCL2 interacting protein 3 (BNIP3)  − 1.9
rs41587635 Neuronal cell adhesion molecule (NRCAM) 1.7
rs110756953 Glycoprotein Ib platelet subunit beta (GB1BB) − 1.8  − 1.7
rs109820008 Adenylate cyclase 8 (ADCY8) 1.7
rs109230217 Desmin (DES) 4.1 3.7
rs108972532 Desmin (DES) 4.1 3.7
rs110397138 Murine retrovirus integration site 1 (MRVI1)  − 1.4  − 1.8
rs41665220 Protein coding (ENS-BTAG00000009359.6)  − 1.2
rs109535431 Calpain 5 (CAPN5)  − 1.2  − 2.0
rs110203175 Chimerin 1 (CHN1)  − 2.5
rs41658581 Calpain 2 (CAPN2)  − 0.6
rs41591969 Complement C3 1.0 1.3
rs108986746 S100 calcium binding protein B (S100B)  − 2.1
rs110435196 Selenoprotein S (SELENOS)  − 0.8  − 0.7
rs42094373 Glutathione S-transferase omega 1 (GSTO1) 3.0
rs110866743 HCLS1 binding protein 3 (HS1BP3)  − 0.9
rs41579631 Selectin E (SELE)  − 2.8
rs41636355 Selectin E (SELE)  − 2.8
rs41646333 Epiregulin (EREG)  − 4.8
rs110380638 Ankyrin repeat domain 37 (ANKRD37)  − 2.0  − 2.4
rs109003203 N-acetylneuraminate pyru-vate lyase (NPL)  − 2.7
ICV
rs41753850 Apolipoprotein A 4 (APOA4) 4.0 3.6
rs109464338 Kelch domain containing 7A (KLHDC7A) 2.0
rs41621303 Aggrecan (ACAN)  − 2.5
rs111006498 Tripartite motif containing 40 (TRIM40) 3.0
rs29014822 Neuralized E3 ubiquitin protein ligase 3 (NEURL3) 3.4
rs41257569 Arylsulfatase B (ARSB)  − 0.8
rs41753850 Apolipoprotein C3 (APOC3) 4.2 4.5
rs43708883 Actinin alpha 2 (ACTN2)  − 2.1
rs110406596 Prominin 2 (PROM2)  − 2.5
rs109082401 TLC domain containing 2 (TLCD2)  − 2.0  − 2.8
rs109080794 Metallothionein 1E (MT1E) 3.8 2.6
rs109502147 Atypical chemokine receptor 1 (ACKR1)  − 0.8  − 1.2  − 2.0
rs41976219 Duodenase-1-like (LOC786126)  − 3.6  − 2.0
rs42581502 Peroxiredoxin 1 (PRDX1)  − 0.7
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that the proportion of T/C heterozygotes and C/C homozygotes with a positive ELISA, culture, and PCR result 
were significantly higher in the cases as compared to control cows. Under the dominant model, the genotypes 
T/C and C/C increased the risk of PTB compared to the genotype T/T; OR = 2.98 (95% CI 1.70–5.24). For the 
rs109859270 locus, the OR for the C/T and T/T genotypes versus the C/C genotype was 1.64 (95% CI 1.24–2.16), 
which indicated that the proportion of animals with one or two copies of the minor allele was significantly higher 
in animals with PTB-associated lesions as compared to control animals without lesions. Overall, the presence 
of the minor alleles in the rs43744169 and rs109859270 increased the PTB risk. Consequently, selecting against 
the rs43744169 and rs109859270 minor alleles may reduce the risk of PTB in cattle.
The presence of the minor allele in the cis‑eQTL‑rs43744169 (T/C) resulted in increased MECOM 
protein levels. The heterozygous genotype (T/C) in the cis-eQTL-rs43744169 was associated with higher 
MECOM gene expression levels (Fig. 3g,  PFDR = 0.00003). Using a bovine MECOM quantitative sandwich ELISA, 
we tested the MECOM protein levels in plasma samples from cows with focal lesions in gut tissues and with the 
three different rs43744169 genotypes (T/T, T/C, C/C). As seen in Fig. 4, the heterozygous (T/C) genotype and 
the minor allele homozygous (C/C) genotype were associated with significantly higher MECOM protein expres-
sion (19.60 and 8.62 ng/ml, respectively) compared with the concentration of MECOM in plasmas from cows 
with the major allele homozygous genotype (T/T, 3.90 ng/ml). This finding confirmed that increases in MECOM 
gene counts did correlate with higher levels of protein expression.
Association between MAP survival and the cis‑eQTL‑rs43744169 genotypes using a mac‑
rophage killing assay. The association between susceptibility to MAP and the cis-eQTL-rs43744169 geno-
types (T/T and T/C) was tested using an ex vivo monocyte-derived macrophages (MDM) killing assay. MDM 
were purified from peripheral blood of uninfected Holstein cattle with the cis-eQTL-rs43744169 genotypes T/T 
(N = 8) and T/C (N = 8) and infected in vitro with a virulent strain of MAP (K10 isolate). Bacterial load (log 
colony-forming units, log CFU) at 2 h and 7 days post-infection (p. i.) was estimated as previously  described35. 
The genotype T/T showed higher MAP uptake at 2 h p.i. (P = 0.0031) and more successful MAP killing at 7 days 
p.i. when compared with the T/C genotype (P = 0.020) (Table 5). These results suggested a significant effect of 
Table 3.  Associations between the rs43744169, rs110345285, rs109859270, and PTB diagnostic results. 
a Statistically significant P-values after Bonferroni correction are shown in bold. b PTB-associated 
histopathological lesion were classified as focal, multifocal, diffuse paucibacillary, diffuse intermediate, diffuse 
multibacillary. c Presence or absence of PTB-histopathological lesions.
Sample eQTL Phenotype
SNPassoc1.9.2-P  valuesa
Codominant Dominant Recessive Overdominant Log-additive
PB
rs43744169 (T/C)
Histopathologyb 0.00011 0.00209 0.00028 0.09028 0.00011
ELISA (OD) 0.00003 0.00059 0.00021 0.04284 0.00002
ELISA + PCR + Cultive 0.00026 0.00012 0.01932 0.00494 0.00005
rs110345285 (T/C) ELISA (OD) 0.00007 0.81100 0.00001 0.26584 0.16103
ICV rs109859270 (C/T) Histopathologyc 0.00226 0.00049 0.45219 0.00098 0.00112
Table 4.  Frequencies of the rs43744169 and rs109859270 genotypes and the odds ratio for each genetic model. 
PB peripheral blood, ICV ileocecal valve, OR odds ratio, 95% CI 95% confidence interval.
Sample eQTL Phenotype Genetic model Genotype
Phenotype frequency
OR (95% CI)Case (%) Control (%)
PB rs43744169 (T/C) ELISA/tissue PCR/tissue culture
Co-dominant
TT 22 (39.3) 592 (63.7) 1.00
TC 27 (49.1) 308 (33.1) 2.71 (1.50–4.88)
CC 6 (10.7) 31 (3.3) 5.36 (1.99–14.41)
Dominant
TT 22 (39.3) 592 (63.7) 1.00
TC-CC 33 (60) 339 (36.4) 2.98 (1.70–5.24)
Log-additive 0,1,2 55(5.7) 931 (94.3) 2.45 (1.63–3.74)
ICV rs109859270 (C/T) Histopathology
Co-dominant
CC 279 (63.0) 367 (73.4) 1.00
CT 148 (33.4) 119 (23.8) 1.65 (1.23–2.19)
TT 16 (3.6) 14 (2.8) 1.54 (0.74–3.22)
Dominant
CC 279 (63.0) 367 (73.4) 1.00
CT-TT 164 (37.0) 133 (26.6) 1.64 (1.24–2.16)
Recessive
CC-CT 427 (96.4) 486 (97.2) 1.00
TT 16 (3.6) 14 (2.8) 1.32 (0.64–2.75)
Log-additive 0,1,2 443 (47.0) 500 (53.0) 1.49 (1.17–1.89)
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the cis-eQTL-rs43744169 heterozygous genotype on bacterial survival within macrophages and confirmed that 
cis-regulatory variation modulates susceptibility to MAP infection.
Discussion
The association between expression and genotype can be tested using linear regression and ANOVA models, as 
well as non-linear techniques including generalized linear and mixed models, Bayesian regression, and models 
accounting for  pedigree30. In the current study, we integrated gene expression data quantified by RNA-Seq and 
SNP data for a cohort of cows naturally exposed to MAP infection and maintained in the same environment. 
Using linear regression analysis, we identified 192 and 48 cis-eQTLs associated with the expression of 145 and 
43 genes in PB and ICV, respectively. Only one of the identified cis-eQTLs, the rs109604269  (PFDR = 0.011), was 
previously found to be associated with susceptibility to MAP infection36. Although the number of individual 
samples in this first part of the study was limited (N = 28), three of the identified cis- eQTLs were associated 
with PTB susceptibility in a larger cattle population (N = 986). Our study provides first insights into the role 
of cis-eQTLs in gene transcription regulation and PTB susceptibility. Since RNA-Seq technology is becoming 
increasingly affordable and provides direct information on the presence of genetic variations at the sequence level, 
further studies should be directed to call SNPs from RNA-Seq data. This approach would provide a secondary 
confirmation of the cis-eQTLs identified in the current study.
Functional analysis of the 235 genes under cis-regulation revealed that there was a significant enrichment 
of the regulation of the acute inflammatory response (GO:0002673) with three genes (C3, S100B, SELENOS) 
involved in this biological process. Heterozygosis in the cis-eQTLs regulating these three genes resulted in 
increased C3, S100B, and SELENOS expression. Higher C3 levels may allow increased opsonophagocytosis and 
effective bacterial clearance of several microorganisms including  mycobacteria37. SELENOS is involved in the 
degradation process of misfolded proteins in the endoplasmic reticulum, and may also have a role in inflamma-
tion  control38. Since inflammation control depends largely on the recruitment of granulocytes (i.e., neutrophils, 
eosinophils, and basophils) to the inflammatory site, chemokine signaling is involved in this process. Neutrophils 
then secrete antibacterial proteins such as the S100 family to destroy microbes. It is well recognized that chronic 
Figure 4.  The MECOM expression is associated with the rs43744169. MECOM protein levels in plasmas from 
homozygous and heterozygous cows in the rs43744169 were measured with a bovine ELISA. Samples were 
selected from the case–control population and grouped according to the rs43744169 genotypes. Cows with the 
alleles T/C (N = 13) and C/C (N = 12) were associated with elevated MECOM protein levels when compared 
with the MECOM levels in the plasmas from cows with the two major alleles T/T (N = 11); P = 0.05 and P = 0.03, 
respectively. The median and the upper and lower quartiles of each group are represented by horizontal 
and vertical lines, respectively. The lowest point is the minimum of the data set and the highest point is the 
maximum of the data set. P-values were calculated using an unpaired t-test. *P-value ≤ 0.05. Each sample is 
represented by a circle on the dot plot.
Table 5.  Genotype effect on MAP survival using a macrophage killing assay. SD standard deviation, CFU 
colony forming units.
rs43744169 Mean log CFU-2 h p. i. (SD) Mean log CFU-7 days p. i. (SD) Ratio (%) MAP survival index (SD) P-value
T/T 4.90 (0.08) 3.51 (0.14) 71 8.46 (0.17) 0.020
T/C 4.77 (0.14) 3.53 (0.11) 74 8.60 (0.15)
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inflammatory diseases develop only when prompt and active innate immunity mechanisms, like granulocytes 
recruitment to the sites of infection, are ineffective or  defective39. In fact, our recent RNA-Seq analysis from 
PB samples of Holstein cattle infected with MAP revealed down-regulation of the C3, S100B, SELENOS genes, 
and of the CXCL8/IL8 signaling pathway, a pathway involved in neutrophils recruitment and resolution of 
 inflammation18. Similarly, patients with CD have decreased secretion of CXCL8/IL8 and reduced neutrophils 
migration to the sites of infection compared with healthy  individuals40. The results presented in the current 
study provide evidence that genetic variants in regulatory regions (cis-eQTLs) can up-regulate the C3, S100B, 
and SELENOS gene expression which might activate a prompt resolution of the infection. However, we did not 
find any association between the cis-eQTLs regulating the C3, S100B, and SELENOS gene expression and PTB 
resistance in our case–control study. Further studies are needed to make sure that the regulation of the C3, S100B, 
and SELENOS gene expression has not a functional role in PTB resistance or tolerance.
When a functional analysis with the identified cis-regulated genes was performed, the cholesterol metabolic 
route (bta04979) was significantly enriched with the apolipoproteins APOA4 y APOC3 involved in this route 
 (PFDR = 0.009, Gene ratio: 2/46). The genes coding for the APOA1 and APOC3 are closely linked on the bovine 
chromosome 15 and have synergistic functions. We found that the heterozygous genotype in the rs41753850 
(C/A) resulted in higher levels of APOA4 and APOC3 expression, while its absence correlated with lower levels 
of gene expression. Recent reports have demonstrated that MAP can manipulate the host lipid metabolism and 
accumulate cholesterol within macrophages which might favor MAP  persistence41. Our results reinforce the 
notion that the lipoprotein metabolism plays an important role in PTB pathogenesis and that PTB-susceptible 
cows might carry alleles that increase lipoprotein production and transport. Consequently, cis-eQTLs associated 
with the APOA4 and APOC3 gene expression may be associated with the PTB risk. In humans, genetic variants 
in the APOA1 –APOC3–APOA4 cluster has been associated with the risk of Alzheimer disease, polycythemia 
induced gastric injury, and metabolic  syndrome42–44. However, we did not find any association between the cis-
eQTLs regulating APOA4 and APOC3 gene expression and PTB risk in our case–control study.
Although the number of normalized reads was low, Matrix eQTL found a significant association between 
the rs43744169 (T/C) and the MECOM gene expression  (PFDR = 0.00003). Next, we found that the presence of 
the minor allele in the rs43744169 (T/C) was associated with positive ELISA, PCR, and bacteriological culture 
results, and with increased risk of clinical PTB. Since our findings provided compelling evidence for the critical 
role of the MECOM in the progression to clinical PTB, it was prioritized in functional studies. Using a MECOM 
quantitative ELISA, we observed that the presence of the minor allele in the rs43744169 was associated with 
higher levels of the MECOM protein in plasma samples from infected cows and with increased MAP survival 
in an ex vivo macrophage killing assay. These findings should be confirmed in a larger population study and, 
additionally, by performing in vivo challenges. Allelic variants affecting the human MECOM gene have been 
associated with human inflammatory bowel  disease45. Mutations resulting in aberrant expression of the MECOM 
have also been found in many types of solid cancers, including colorectal cancer, as well as in acute myeloid 
 leukemia46,47. Previous scientific evidence showed that the MECOM acts as an oncogene regulating signaling 
pathways that lead to increased tumor  proliferation48. More specifically, cell line assays have demonstrated a role 
for the MECOM in the transcriptional control of c-fos, transforming growth factor β (TGF-β) and the activator 
protein 1 (AP1) proliferative  pathway49. The MECOM also binds to the promoter regions of the majority of genes 
involved in the JAK-STAT signaling  pathway50. Excessive JAK-STAT signaling activation results in numerous 
inflammatory and hematopoietic disorders. Recent findings indicate that the MECOM is up-regulated by inflam-
matory stimuli, including bacteria, and that mutations in the MECOM made mice more susceptible to bacterial 
 infections51. The MECOM has also a recognized function as a crucial regulator of the nuclear factor-kappa β 
(NF-κβ)-mediated inflammatory  response52. NF-κβ is a critical factor in the gut immune responses to pathogens 
and in promoting inflammation-associated carcinoma in the gastrointestinal  tract53. Our findings suggest that 
genetic variants in a cis-eQTL affecting the expression of the MECOM, a transcriptional regulator of the NF-κβ 
inflammatory response, may cause an uncontrolled and aberrant inflammatory response which might exacerbate 
tissue injury in PTB-infected cattle. This is in agreement with Kiser et al., who found an association between 
seven genes linked to the NF-κβ pathway (DUSP10, IKBKB, NR4A1, PRKCA, SLC2A5, TGFB2, and PIK3R1) 
and MAP tissue infection in two Holstein populations using gene set enrichment analysis-SNP (GSEA-SNP)16.
Our case–control association study revealed a second cis-eQTL, the rs110345285 (T/C), associated with 
the up-regulation of the eEF1A2 gene expression and with high levels of MAP antibodies. More specifically, 
increased ELISA (OD) values were associated with the less frequent homozygous genotype (C/C) in the cis-
eQTL-rs110345285. The eEF1A2 is a protein translation factor involved in protein synthesis and with important 
anti-apoptotic, migration and pro-metastasis functions on cancer  development54,55. Mechanistic studies revealed 
that the PI3K/Akt /NF-κβ and JAK/STAT signaling pathways play an important role in mediating the effects of 
the eEF1A256. eEF1A2 expression increases the formation of filopodia structures that have an important role in 
driving cell migration and  invasion57. High eEF1A2 expression is associated with severe tumor grades and metas-
tasis in several cancer cell lines and with some cases of multiple myeloma, a plasma cell neoplasm of  humans58. 
Furthermore, the eEF1A2 blocks apoptosis and favors viral  replication59. In agreement with this, our results 
suggested that PTB-infected cows carrying the risk allele in the rs110345285 (C) and exhibiting high levels of 
eEF1A2 might have a reduced probability of survival compared to their non-eEF1A2-expressing counterparts.
Our case–control association analysis revealed a third significant association between the cis-eQTL-
rs109859270 (C/T) and the absence or presence of PTB-histopathological lesions. For the rs109859270 locus, 
the OR for the C/T and T/T genotypes versus the C/C genotype was 1.64 (95% CI 1.24–2.16), which indicated 
that the proportion of animals with one or two copies of the minor allele were significantly higher in animals with 
PTB-associated lesions as compared to control animals without lesions. In addition, the heterozygous genotype 
in the cis-eQTL-rs109859270 was associated with the up-regulation of the U1 spliceosomal RNA expression. 
Splicing is performed by a spliceosome that assembles on each intron and predominantly comprises U1, U2, 
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U4, and U5, and U6 uridyl-rich small nuclear RNPs (snRNPs) in equal  stoichiometry60,61. U1 snRNPs plays an 
essential role in defining the 5′ end splice site by RNA-RNA base pairing. Besides its splicing role, U1 snRNPs 
protects pre-mRNAs from drastic premature termination by premature cleavage and polyadenylation (PCPA) at 
more proximal alternative polyadenylation sites, which has already been proved in activated immune, neuronal, 
and cancer  cells62. U1 snRNA abnormalities can cause defects in pre-mRNA splicing, which are considered as a 
primary cause of several  diseases63. In other words, mammalian cells require U1 snRNA with expression levels in 
a restricted range to prevent drastic premature termination of the nascent pol II transcripts by  PCPA64. In human 
macrophages, U1 snRNA over-expression has been associated with impairment of autophagosome-lysosome 
 fusion65. Recent studies reported that the infection of human macrophages with Mycobacterium tuberculosis 
(MTb) results in massive alterations in the pattern of RNA splicing in the  host66,67. Furthermore, two genes related 
to macrophage function, the monocyte to macrophage differentiation gene (MDM) and adenosine deaminase 
(ADA) genes, were differentially spliced in MAP-infected ileum suggesting a possible mechanism by which 
MAP escapes the host innate immune  response68. Our findings suggested that the heterozygous genotype in 
the cis-eQTL-rs109859270 (C/T) resulted in increased U1 spliceosomal RNA expression levels. In contrast, 
the most frequent homozygous genotype (C/C) maintained the U1 snRNA expression levels in a restricted 
range and was associated with a more controlled risk of infection. Further studies are required to understand 
the mechanisms of splicing and alternative splicing regulation upon MAP infection and how they can impact 
immune responses in cattle.
Conclusions
The identification of functional variants (cis-eQTLs) followed by a case–control association analysis allowed the 
identification of three cis-eQTLs regulating the expression of the MECOM, eEF1A2, and U1 spliceosomal RNA 
expression and their validation as significantly associated with PTB susceptibility in a larger cattle population. 
It should be emphasized that MECOM, eEF1A2, and U1 risk alleles have shown detrimental effects in other 
inflammatory diseases including human IBD and colorectal cancer. Furthermore, the introduction of the cis-
eQTLs described in the current study into marker-assisted breeding programs might reduce the disease through 
selection, reduce economic losses, and improve animal health.
Materials and methods
Ethics statement. Experimental procedures were approved by the Animal Ethics Committee of the Ser-
vicio Regional de Investigation y Desarrollo Agroalimentario (SERIDA) and authorized by the Regional Con-
sejeria de Agroganadería y Recursos Autoctonos of the Principality of Asturias (authorization code PROAE 
29/2015). All the procedures were conducted following 2012/63/EU of the European Parliament. Blood, fecal, 
and tissue samples were collected by trained personnel and following good veterinary practice. Animals used in 
the case–control study were sampled under pertinent legislation for safeguarding animal welfare (Basque Gov-
ernment Decree 454/1994, Spanish Government Law 32/2007, Royal decree 731/2007, and European council 
regulation number 1099/2009).
Animals and PTB diagnosis. PB and ICV samples were collected from fourteen Holstein Friesian cows 
from a single commercial dairy farm in Asturias (Spain) at the time of slaughter. This farm was selected for 
sample collection based on PTB clinical cases, with some cows confirmed by necropsy examination. The mean 
prevalence of the disease in the farm (period 2016 to 2019) was estimated at 6.29% by ELISA for the detection of 
MAP antibodies. Infection status was determined by histopathological analysis of gut tissues, ELISA, bacterio-
logical culture, and PCR assays as previously  described28. For the case–control study, the infection status of 986 
Holstein Friesian cattle from eight Northeast Spain regions was determined by histopathological analysis of gut 
tissues, ELISA for MAP antibodies detection, and tissue culture and PCR for MAP  detection32. Animals were 
5.5 years old on average. Except for six animals that were aged between 18 and 23.2 months, the majority of the 
animals were adults (2 years or older).
Genotyping. Blood samples were collected from the coccygeal (tail) vein into EDTA Vacutainer tubes (BD 
Vacutainer System, Becton, Dickinson, and Company, Sparks, MD, USA). Blood samples were centrifuged at 
2500×g for 20 min at 4  °C and buffy layers containing white blood cells were collected. Genomic DNA was 
extracted from the blood buffy coat using the QIAmp DNA Blood Mini Kit according to the manufacturer’s 
instructions (Qiagen, Hilden, Germany). Purified genomic DNA was quantified spectrophotometrically and 
subsequently genotyped on the EuroG10K BeadChip at the molecular genetic laboratory service of the Span-
ish Federation of Holstein Cattle (CONAFE) using the Infinium iScan software for allele assignation (Illumina, 
San Diego, CA) as previously  described28. The EuroG10K BeadChip is a development by EuroGenomics and its 
collaborators.
Gene expression data. In the current study, the alignment files from our previous RNA-Seq study were 
 used18. Briefly, PB samples were collected by venipuncture of the coccygeal vein using PAXgene Blood RNA 
tubes (2.5 ml) (Qiagen, Hilden, Germany). Total RNA was purified from the PB samples using the PAXgene 
blood RNA kit according to the manufacturer´s instructions (Qiagen, Hilden, Germany). For RNA isolation, 
150–200 mg of ICV were harvested and immediately submerged in 2 ml of RNA later (Sigma, St. Louis, MO). 
Purification of RNA was performed using the RNeasy Mini Kit according to the manufacturer’s instructions 
(Qiagen, Hilden, Germany). Residual genomic DNA was removed using DNase digestion with RNase-free 
DNase I amplification grade following the recommended protocol (Invitrogen, Spain). The concentration and 
quality of the total RNAs were measured using an Agilent Bioanalyzer 2100 (Agilent Technologies, Santa Clara, 
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CA, US). All samples had an RNA integrity value of 7 or greater. Approximately 250 ng of RNA were used for 
RNA-Seq library preparation using the Illumina NEBNext Ultra Directional RNA Library preparation kit fol-
lowing the manufacturer´s instructions (Illumina, San Diego, CA, US). Libraries quality was assessed using an 
Agilent Bioanalyzer and Agilent high sensitivity DNA chip to confirm that the insert sizes were 188–274 bp for 
all the individual libraries. RNA-Seq libraries were single-end sequenced in a 1 × 75 bp format using an Illu-
mina NextSeq 500 sequencer at the Genomic Unit of the Scientific Park of Madrid, Spain. All the libraries were 
sequenced generating an average of 22.31 million raw reads per library with a Phred quality score > 30. The raw 
reads were filtered by their length (minimum size 75 bp long) and percentage of ambiguous base N less than 
10% using Prinseq-lite 0.20.425. After quality control, reads were subsequently mapped to the Bos Taurus refer-
ence genome (Bos_taurus.UMD3.1. version 87) with TopHat 2.1.126. The resulting alignment files (.bam) were 
provided to the Cufflinks package 2.2.169 to calculate gene expression levels and genes differentially expressed in 
the infected animals with focal/multifocal or diffuse lesions versus the control group.
In the current study, the alignment files (.bam) from our previous RNA-Seq  study18 were used to generate a 
table of reads for each sample using Rsubread27. The number of reads mapped to 24,616 genes was counted using 
the function feature counts in the Rsubread package. Next, the analysis of differential expression between the 
cows with focal/multifocal or diffuse lesions versus control cows was conducted using DESeq229. The differentially 
expressed genes were selected as those with an adjusted P- value  (PFDR) ≤ 0.05.
cis‑eQTL analysis. Gene expression data (read counts) were normalized with the mean-of-ratios method 
included in the DESeq2  package29. Then, R Matrix eQTL 2.2 was used to test for associations between each SNP-
normalized counts by modeling the effect of genotype as additive linear (least square model), where the null 
hypothesis is no association between genotype and gene expression. This tool implements matrix covariance 
calculation and efficiently runs linear regression analysis for cis-eQTL  discovery30. cis-eQTLs were calculated 
by selecting gene variants on the same chromosome that are located within 1 Mb upstream of the TSS of a gene 
locus. Specific details regarding the matrix structure in Matrix eQTL have been previously  described70. Briefly, 
S and G denote the genotype matrix and the gene expression matrix, respectively. Each row of these matrices 
holds different measurements for a single SNP among samples and a single gene across samples, respectively. 
Data matrices are sliced into blocks of up 10,000 variables. Then, gene expression and genotype matrices are 
standardized. For each pair of blocks, the correlation matrix for a relevant block is calculated and Matrix eQTL 
checks if the absolute value of any correlation exceeds a predefined threshold. Then, Matrix eQTL calculates the 
P-values only for those SNP-normalized counts associations selected based on their correlations being larger 
than the threshold. Matrix eQTL uses the false discovery rate (FDR)71 to adjust for multiple hypotheses testing 
and to identify significant cis-eQTLs  (PFDR ≤ 0.05). FDR is the expected proportion of false positives among all 
the significant tests.
Functional enrichment analysis. Genes with significant cis-eQTLs were investigated for enrichment of 
biological processes using gene ontology  categories72 within the cluster Profiler Bioconductor package 3.10.131 
and Panther  database73. A threshold for significant enrichment was set at  PFDR ≤ 0.05 after adjustment with the 
Benjamini–Hochberg  procedure71.
Case–control study. Associations between genotypes-phenotypes were assessed by logistic regression 
analysis using the WGassociation function of SNPassoc 1.9.2 under five different genetic models (co-dominant, 
dominant, recessive, over-dominant, and log-additive)34. The response variable can be binary (positive or nega-
tive diagnostic result) or continuous (ELISA OD values and PTB-associated lesions classified according to their 
severity in five grades). The genotypes of the cis- eQTLs were included as possible explanatory variables. The 
WGassociation function fits individual logistic regression models to each of the class variables (genotypes) using 
age as a covariate. P-values were adjusted using the Bonferroni correction (based on the total number of markers 
tested) for multiple comparisons. For each cis-eQTL and genetic model, the function WGstats of SNPassoc 1.9.2. 
provided genotype frequencies, OR (or mean differences for quantitative traits), and 95% CI with the major 
homozygous genotype deemed as the baseline.
Bovine MECOM ELISA kit. The levels of MECOM protein in plasma samples (50 µl) were assessed by using 
a quantitative sandwich ELISA according to the manufacturer’s instructions (MyBioSource, San Diego, US). 
The sensitivity of the kit is 1.0 ng/ml and the detection range is 3.12–100 ng/ml. Briefly, standards and samples 
(50 µl) were added in duplicate into an appropriate ELISA plate. One hundred microliters of the horseradish 
peroxidase-conjugated antibody was added to each well. After incubation for 60 min at 37 °C, the plate was 
washed four times with 350 µl of wash solution and incubated with 50 µl of 3, 3′, 5, 5′-Tetramethylbenzidine for 
15 min at 37 °C in the dark. After adding 50 µl of stop solution into each well, the OD values were measured 
in an ELISA reader at 450 nm (Thermo Scientific Multiskan, US). We average the duplicate readings for each 
standard and sample to subtract the average OD of the blank. A standard curve was generated by plotting the 
mean OD values of each standard on the vertical axis and the corresponding concentration on the horizontal 
axis. The concentration level of the MECOM in each sample was interpolated from the standard curve. Statistical 
analysis was performed using an unpaired t-test for comparison between two groups (GraphPad Prism 8, San 
Diego, California, US). Differences were considered significant when P ≤ 0.05.
Macrophage killing assay. Peripheral blood was drawn from healthy Holstein cows into heparinized 
Vacutainer tubes (Becton, Dickinson and Company, Sparks, MD), diluted 1:2 in Hanks balanced salt solution 
(HBSS), layered over 10 ml of Ficoll-Paque gradient (1.084 g/cm3) (GE HelthCare, Uppsala, Sweden) and cen-
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trifuged at 900×g for 30 min. The cell interphase was collected and centrifuged at 400×g for 10 min to remove 
platelets from peripheral blood mononuclear cells (PBMC). PBMC were resuspended in RPMI-1640 supple-
mented with 20  mM l-glutamine, 10% heat-inactivated bovine serum, 100 U/ml penicillin G, and 100  mg/
ml streptomycin sulfate (Lonza, Spain) and seeded at a density of 1 × 106 PBMC/ml into 24-well tissue culture 
plates. After 2 h at 37 °C in a humidified 5%  CO2 incubator, non-adherent cells were removed. Adherent cells 
were incubated for 7 days at 37 °C to allow differentiation to MDM before infection. Differentiated MDM were 
inoculated in triplicate with a single-cell suspension of MAP reference strain K10 at a multiplicity of infection 
(bacteria:cells) of 10:1. After 2 h, the supernatant was removed, and the cells were washed twice with HBSS to 
remove extracellular bacteria. Infected MDM were lysed at this time (2 h p.i.) or cultured at 37 °C for 7 days 
in fresh medium. At each time point, the supernatant was aspirated and infected MDM were lysed by vigorous 
pipetting with 0.5 ml of 0.1% Triton X-100 (Sigma-Aldrich) in sterile water for 10 min. Supplemented Mycobac-
teria Growth indicator tubes (MGIT) (Becton, Dickinson and Company, Sparks, MD, US) were inoculated with 
0.1 ml of each initial bacterial suspension and with the 2 h and 7 d p. i. cell lysates. The tubes were incubated at 
37 ± 2 °C for up to 41 days in a Bactec MGIT 960 instrument (Becton, Dickinson and Company). The earliest 
instrumental indication of positivity (i.e., time to detection [TTD]) for each tube was recorded. The predicted 
number of bacteria in each positive tube was calculated using previously generated mathematical equations that 
relate TTD (in days) to the estimated log  CFUs35. The CFU ratios between 2 h and 7 days p.i. were calculated by 
dividing the estimated log CFUs at day 7 by that at 2 h p.i. MAP survival index was estimated as the square root 
CFU ratio × 100. Higher values of the MAP survival index reflect higher susceptibility to infection. A student’s 
t-test was performed for comparison of the survival indexes between two groups (GraphPad Prism 8, San Diego, 
CA, US). Differences were considered significant when P-values were ≤ 0.05.
Data availability
RNA-Seq raw data have been deposited in the NCBI Gene Expression Omnibus (GEO) database under the acces-
sion number GSE137395. SNPs datasets will not be made publically available as the data were generated from 
private-owned cattle, with a legal commitment to confidentiality. Researchers may request access to the data and 
consideration will be given to individuals following the conclusion of a confidentiality agreement.
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